Cancer in children with rare inborn immune defect: High cure rate if treated early

Cancer in children with rare inborn immune defect: High cure rate if treated early

(Vienna, 03.12.2020) New research data highlight a marked predisposition to lymphoma, a type of cancer, in children harboring specific gene mutations. A significant fraction of these rare mutations also cause inborn immune defects associated with recurrent infections. Collaborating closely with leading centers across the world, researchers investigated patients bearing recently…